Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 30;11(1):13594.
doi: 10.1038/s41598-021-93124-9.

Identification of subtypes of anticancer peptides based on sequential features and physicochemical properties

Affiliations

Identification of subtypes of anticancer peptides based on sequential features and physicochemical properties

Kai-Yao Huang et al. Sci Rep. .

Abstract

Anticancer peptides (ACPs) are a kind of bioactive peptides which could be used as a novel type of anticancer drug that has several advantages over chemistry-based drug, including high specificity, strong tumor penetration capacity, and low toxicity to normal cells. As the number of experimentally verified bioactive peptides has increased significantly, various of in silico approaches are imperative for investigating the characteristics of ACPs. However, the lack of methods for investigating the differences in physicochemical properties of ACPs. In this study, we compared the N- and C-terminal amino acid composition for each peptide, there are three major subtypes of ACPs that are defined based on the distribution of positively charged residues. For the first time, we were motivated to develop a two-step machine learning model for identification of the subtypes of ACPs, which classify the input data into the corresponding group before applying the classifier. Further, to improve the predictive power, the hybrid feature sets were considered for prediction. Evaluation by five-fold cross-validation showed that the two-step model trained with sequence-based features and physicochemical properties was most effective in discriminating between ACPs and non-ACPs. The two-step model trained with the hybrid features performed well, with a sensitivity of 86.75%, a specificity of 85.75%, an accuracy of 86.08%, and a Matthews Correlation Coefficient value of 0.703. Furthermore, the model also consistently provides the effective performance in independent testing set, with sensitivity of 77.6%, specificity of 94.74%, accuracy of 88.99% and the MCC value reached 0.75. Finally, the two-step model has been implemented as a web-based tool, namely iDACP, which is now freely available at http://mer.hc.mmh.org.tw/iDACP/ .

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Analytical flowchart of iDACP including data collection, data preprocessing and type grouping, features investigation, feature sets combination, model construction and evaluation, and independent testing.
Figure 2
Figure 2
Investigation of composition of twenty amino acids of ACPs and non-ACPs.
Figure 3
Figure 3
Investigation of composition of twenty amino acids between the N- and C-terminal regions of ACPs.
Figure 4
Figure 4
The frequency differences of 20 × 20 amino acid pairs between ACPs and non-ACPs.
Figure 5
Figure 5
Comparison of the physicochemical property profiles between ACPs and non-ACPs.
Figure 6
Figure 6
Position-specific amino acid composition of the N- and C-terminal regions in the different subtypes of ACPs.
Figure 7
Figure 7
Physicochemical property profiles of N- and C-terminus in the different subtypes of ACPs.

References

    1. Zahreddine H, Borden KL. Mechanisms and insights into drug resistance in cancer. Front. Pharmacol. 2013;4:28. doi: 10.3389/fphar.2013.00028. - DOI - PMC - PubMed
    1. Si W, et al. The role and mechanisms of action of microRNAs in cancer drug resistance. Clin. Epigenetics. 2019;11(1):25. doi: 10.1186/s13148-018-0587-8. - DOI - PMC - PubMed
    1. Li X, et al. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J. Natl. Cancer Inst. 2008;100(9):672–679. doi: 10.1093/jnci/djn123. - DOI - PubMed
    1. Mansoori B, et al. The different mechanisms of cancer drug resistance: A brief review. Adv. Pharm. Bull. 2017;7(3):339–348. doi: 10.15171/apb.2017.041. - DOI - PMC - PubMed
    1. Hoskin DW, Ramamoorthy A. Studies on anticancer activities of antimicrobial peptides. Biochim. Biophys. Acta. 2008;1778(2):357–375. doi: 10.1016/j.bbamem.2007.11.008. - DOI - PMC - PubMed

Publication types